2Neutel JM,Smith DH,Wallin D,et al.A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension.Am J Hypertens,1994,7:623-628.
4Yang HJ,Kim JG,Lim YS,et al.Nicardipine versus nitroprusside infusion as antihypertensive therapy in hypertensive emergencies.J Int Med Res,2004,32:118-123.
6Lim SY,Jang JH.Surh YJ.Induction of cyclooxygenase-2 and peroxisome proliferators-activated receptor-gamma during nitric oxide-induced apoptotic PC12 cell death.Ann N Y Acad Sci,2003,1010:648-658.
7Lebuffe G,Dosseh ED,Tek G,et al.The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas.Anaesthesia,2005,60:439-444.
2Vaile JC, Jordan PJ, Stallard TJ, et al. The effects of acute and chronic dihydropyridine calcium antagonist therapy on baroreflex sensitivity: a re-analysis using the sequence method [J]. J Hum Hypertens, 2000, 14(3): 189-194.
3White WB, Sics DA, Calhoun D, et al. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising[J]. Am Hear
4Cioffi G, Stefenelli C, Tarantini L, et al. Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients ＞70 years of age with left ventricular systolic dysfunction and decompensated chronic heart failure [J].Am J Cardio
5Vincent JL, Berlot G, Preiser JC, et al. Intravenous nicardipine in the treatment of postoperative arterial hypertension [J]. J Cardiothorac Vasc Anesth, 1997,11 (2): 160- 164.
6Chan MK, Tucker AT, Madden S, et al. Erythromelalgia: an endothelial disorder responsive to sodium nitroprusside [J].Arch Dis Child, 2002, 87(3) : 229-230.
7Lund-Johansen P. Blood pressure and heart rate responses during physical exercise in hypertension : modifications by drug treatment [J]. Eur Heart J, 1999, 1(B Suppl ):B10-B17.
8Dorman T, Thompson DA, Breslow MJ, et al. Nicardipine versus nitroprusside for breakthrough hypertension following carotid endarterectomy [J]. J Clin Anesth, 2001, 13 (1): 16 -19.
91999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee [J]. J Hypertens, 1999, 17(2): 151- 183.
10He GW, Yang CQ. Comparative study on calcium channel antagonists in the human radial artery: clinical implications [J]. J Thorac Cardiovasc Surg, 2000, 119 ( 1 ) : 94- 100.
4Krischek B, Kasuya H, Onda H, et al. Nicardipine prolongedrelease implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients. Neurol Med Chir (Tokyo), 2007,47 : 389-394.
5Mocco J, Rose JC, Komotar RJ, et al. Blood pressure management in patients with intracerebral and subarachnoid hemorrhage. Neurosurg Clin N Am, 2006,17: 25-40.
6KanK, HattoriH, HosonoA, et al. Anesthetic practices and use of brain protective therapies for cerebral aneurysmsurgery in Japan. Masui, 2007,56:590-594.
7Degoute CS. Controlled hypotension: a guide to drug choice. Drugs, 2007,67:1053-1076.
8Hermida R C, Ayala D E, Calvo C, et al. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension [J]. Hypertension, 2005, 46(2) : 1053-1059.
9Redon J, Campos C, Narciso M L, et al. Prognostic value of amulatory blood pressure monitoring in refractory hypertension: a prospective study [J].Hypertension, 2004, 31(6): 712-718.
10Vidt D G. Pathogenesis and treatment of resistant hypertension [J]. Minerva Med, 2003,94(6) : 201-214.
